1. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
- Author
-
Botten, Giovanni A., Zhang, Yuannyu, Fuda, Franklin, Koduru, Prasad, Weinberg, Olga K., Slone, Tamra L., Zheng, Ruifang, Dickerson, Kathryn E., Gagan, Jeffrey R., and Chen, Weina
- Subjects
ACUTE leukemia ,EXTRAMEDULLARY diseases ,GENE enhancers ,NUCLEOTIDE sequencing ,PHENOTYPES - Abstract
Summary: T/myeloid mixed phenotype acute leukaemia (MPAL) is a rare aggressive acute leukaemia with poorly understood pathogenesis. Herein, we report two cases of T/myeloid MPAL harbouring BCL11B‐associated structural variants that activate TLX3 (TLX3::BCL11B‐TLX3‐activation) by genome sequencing and transcriptomic analyses. Both patients were young males with extramedullary involvement. Cooperative gene alterations characteristic of T/myeloid MPAL and T‐lymphoblastic leukaemia (T‐ALL) were detected. Both patients achieved initial remission following lineage‐matched ALL‐based therapy with one patient requiring a lineage‐switched myeloid‐based therapy. Our study is the first to demonstrate the clinicopathological and genomic features of TLX3::BCL11B‐TLX3‐activated T/myeloid MPAL and provide insights into leukaemogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF